Literature DB >> 33507594

Luteolin, inflammation and cancer: Special emphasis on gut microbiota.

Laura Franza1, Valentina Carusi2, Eleonora Nucera2, Franco Pandolfi2.   

Abstract

Luteolin belongs to the family of flavonoids, which have anti-inflammatory functions, potentially useful in a clinical context, particularly for patients suffering from cancer, neuropsychiatric disorders, inflammatory bowel conditions. This peculiarity has been used for centuries in traditional Chinese medicine, for many different diseases. Its anti-inflammatory effects might be particularly relevant in cancer, with some studies reporting anti-angiogenesis, anti-metastatic, and apoptotic effects on cancer cells by luteolin and other flavonoids. In this article, we analyze the anti-inflammatory role of luteolin, discussing the pathways it may act on. We will then discuss the possible role of microbiota in inflammatory modulation by luteolin. Finally, the possible therapeutic applications of luteolin's anti-inflammatory properties will be analyzed, with a particular focus on cancer.
© 2021 International Union of Biochemistry and Molecular Biology.

Entities:  

Keywords:  flavonoids; immunology; inflammation; luteolin; microbiota

Mesh:

Substances:

Year:  2021        PMID: 33507594     DOI: 10.1002/biof.1710

Source DB:  PubMed          Journal:  Biofactors        ISSN: 0951-6433            Impact factor:   6.113


  8 in total

Review 1.  Advances in Immunosuppressive Agents Based on Signal Pathway.

Authors:  Zhiqing Xu; Ming Chu
Journal:  Front Pharmacol       Date:  2022-05-26       Impact factor: 5.988

Review 2.  Vaccines, Microbiota and Immunonutrition: Food for Thought.

Authors:  Laura Di Renzo; Laura Franza; Diego Monsignore; Ernesto Esposito; Pierluigi Rio; Antonio Gasbarrini; Giovanni Gambassi; Rossella Cianci; Antonino De Lorenzo
Journal:  Vaccines (Basel)       Date:  2022-02-15

3.  Luteolin attenuates the chemoresistance of osteosarcoma through inhibiting the PTN/β-catenin/MDR1 signaling axis by upregulating miR-384.

Authors:  Tao Qin; Wenjing Zhu; Xiaoli Kan; Ling Li; Dapeng Wu
Journal:  J Bone Oncol       Date:  2022-04-13       Impact factor: 4.491

Review 4.  Flavonols and Flavones as Potential anti-Inflammatory, Antioxidant, and Antibacterial Compounds.

Authors:  Maria do Socorro S Chagas; Maria D Behrens; Carla J Moragas-Tellis; Gabriela X M Penedo; Adriana R Silva; Cassiano F Gonçalves-de-Albuquerque
Journal:  Oxid Med Cell Longev       Date:  2022-09-06       Impact factor: 7.310

5.  The interactions between traditional Chinese medicine and gut microbiota: Global research status and trends.

Authors:  Shanshan Yang; Shaodong Hao; Qin Wang; Yanni Lou; Liqun Jia; Dongmei Chen
Journal:  Front Cell Infect Microbiol       Date:  2022-09-12       Impact factor: 6.073

Review 6.  Roles of mitochondrial fusion and fission in breast cancer progression: a systematic review.

Authors:  Jixiang Xing; Luyao Qi; Xiaofei Liu; Guangxi Shi; Xiaohui Sun; Yi Yang
Journal:  World J Surg Oncol       Date:  2022-10-03       Impact factor: 3.253

7.  In Silico and In Vitro Identification of Pan-Coronaviral Main Protease Inhibitors from a Large Natural Product Library.

Authors:  Nasim Shahhamzehei; Sara Abdelfatah; Thomas Efferth
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-03

8.  Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis.

Authors:  Jiaqin Liu; Jian Liu; Xiaoliang Tong; Weijun Peng; Shanshan Wei; Taoli Sun; Yikun Wang; Bikui Zhang; Wenqun Li
Journal:  Drug Des Devel Ther       Date:  2021-07-28       Impact factor: 4.162

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.